Baidu
map
GENET MED 润色咨询

GENETICS IN MEDICINE

出版年份：1998 年文章数：2360 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：5.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-28 Mia

    撰写摘要有什么要点？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-27 衣谷

    摘要需要详细到什么程度？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2018-07-25 1207c3c3m39(暂无昵称)

    同问wangyajian 2018-05-29 发表::
    四天了.还是decision in process.这个是还在编辑手里?    wangyajian 2018-05-29 09:20:00 发表:
    四天了.还是decision in process.这个是还在编辑手里?

    wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2018-05-29 wangyajian

    四天了.还是decision in process.这个是还在编辑手里?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-09-15 1381f150e3m

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-08-01 1381f150e3m

    有没有人能分享一下文章发表的经验？谢谢～

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-07-16 13305510181

    涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1090807, encodeId=ded2109080ecb, content=撰写摘要有什么要点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090808, encodeId=44f51090808de, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559545, encodeId=c65f559545d7, content=同问<span class="quote">wangyajian 2018-05-29 发表::<br>四天了.还是decision in process.这个是还在编辑手里?</span><span class="quote">wangyajian 2018-05-29 09:20:00 发表:<br>四天了.还是decision in process.这个是还在编辑手里?</span>, beContent=wangyajian 2018-05-29 发表:: 四天了.还是decision in process.这个是还在编辑手里?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4d12183969, createdName=1207c3c3m39(暂无昵称), createdTime=Wed Jul 25 00:00:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556555, encodeId=f145556555f8, content=四天了.还是decision in process.这个是还在编辑手里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/81d5200eb0d9206bf752baf28ce8f57b/2e6ada14872909586c29d6aacb39fb1e.jpg, createdBy=4e301621016, createdName=wangyajian, createdTime=Tue May 29 09:20:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547212, encodeId=08a054e212c5, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：体细胞变异方面的文章.2017.7.5日投稿.8.18拿到一审意见.两个reviewer,评价都还算积极.但是都提了很多问题.没有让补实验.主要需要修改的是文中多处的表达方式.8.21日修回.9.13拿到终审意见- 感觉这个杂志对于人类疾病主要致病基因的新发现或者是对于很可能会改变遗传咨询策略以及检测手段选择原则的文章会更感兴趣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Fri Sep 15 12:55:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544990, encodeId=5299544990cd, content=有没有人能分享一下文章发表的经验？谢谢～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a94a2076864, createdName=1381f150e3m, createdTime=Tue Aug 01 13:11:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544357, encodeId=74d954435e36, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481506, encodeId=acbb48150698, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=616, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦，明年会不会再涨？

    0

共12条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map